ArticleOncotarget2016

CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia.

Arnau Montraveta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.